242 related articles for article (PubMed ID: 19781418)
1. Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies.
Davlouros PA; Arseniou A; Hahalis G; Chiladakis J; Mazarakis A; Damelou A; Karakantza M; Paliogianni F; Karogiannis N; Alexopoulos D
Am Heart J; 2009 Oct; 158(4):585-91. PubMed ID: 19781418
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.
Widimsky P; Motovská Z; Simek S; Kala P; Pudil R; Holm F; Petr R; Bílková D; Skalická H; Kuchynka P; Poloczek M; Miklík R; Maly M; Aschermann M;
Eur Heart J; 2008 Jun; 29(12):1495-503. PubMed ID: 18441320
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.
Wolfram RM; Torguson RL; Hassani SE; Xue Z; Gevorkian N; Pichard AD; Satler LF; Kent KM; Waksman R
Am J Cardiol; 2006 Apr; 97(7):984-9. PubMed ID: 16563901
[TBL] [Abstract][Full Text] [Related]
4. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
[TBL] [Abstract][Full Text] [Related]
6. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
[TBL] [Abstract][Full Text] [Related]
7. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
[TBL] [Abstract][Full Text] [Related]
8. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.
Feldman DN; Fakorede F; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2010 Feb; 105(3):323-32. PubMed ID: 20102943
[TBL] [Abstract][Full Text] [Related]
11. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.
Patti G; Bárczi G; Orlic D; Mangiacapra F; Colonna G; Pasceri V; Barbato E; Merkely B; Edes I; Ostojic M; Wijns W; Di Sciascio G
J Am Coll Cardiol; 2011 Oct; 58(15):1592-9. PubMed ID: 21958886
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
Di Sciascio G; Patti G; Pasceri V; Gatto L; Colonna G; Montinaro A;
J Am Coll Cardiol; 2010 Aug; 56(7):550-7. PubMed ID: 20688209
[TBL] [Abstract][Full Text] [Related]
13. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Lewis BS; Murphy SA; McCabe CH; Braunwald E;
JAMA; 2005 Sep; 294(10):1224-32. PubMed ID: 16143698
[TBL] [Abstract][Full Text] [Related]
14. Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis.
Bonello L; Camoin-Jau L; Armero S; Com O; Arques S; Burignat-Bonello C; Giacomoni MP; Bonello R; Collet F; Rossi P; Barragan P; Dignat-George F; Paganelli F
Am J Cardiol; 2009 Jan; 103(1):5-10. PubMed ID: 19101221
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study.
Patti G; Colonna G; Pasceri V; Pepe LL; Montinaro A; Di Sciascio G
Circulation; 2005 Apr; 111(16):2099-106. PubMed ID: 15750189
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.
Leonardi S; Mahaffey KW; White HD; Gibson CM; Stone GW; Steg GW; Hamm CW; Price MJ; Todd M; Dietrich M; Gallup D; Liu T; Skerjanec S; Harrington RA; Bhatt DL
Am Heart J; 2012 May; 163(5):768-776.e2. PubMed ID: 22607853
[TBL] [Abstract][Full Text] [Related]
17. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.
Szük T; Gyöngyösi M; Homorodi N; Kristóf E; Király C; Edes IF; Facskó A; Pavo N; Sodeck G; Strehblow C; Farhan S; Maurer G; Glogar D; Domanovits H; Huber K; Edes I
Am Heart J; 2007 Feb; 153(2):289-95. PubMed ID: 17239691
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel pretreatment before primary percutaneous coronary stenting in patients with acute ST-segment elevation myocardial infarction: comparison of high loading dose (600 mg) versus low loading dose (300 mg).
Jung JH; Min PK; Lee SH; Sung CW; Choi S; Cho JR; Lee N; Byun KH
Coron Artery Dis; 2009 Mar; 20(2):150-4. PubMed ID: 19301464
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
Mangiacapra F; Muller O; Ntalianis A; Trana C; Heyndrickx GR; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
Am J Cardiol; 2010 Nov; 106(9):1208-11. PubMed ID: 21029814
[TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
